XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar syazic (71.52) Submitted: 2/26/2010 9:37:08 AM : Outperform Start Price: $8.40 XNPT Score: -49.27

XNPT oversold by shorties.. Intrinsic value is $10-18.

Featured Broker Partners


Advertisement